Literature DB >> 21850326

Pseudoceramines A-D, new antibacterial bromotyrosine alkaloids from the marine sponge Pseudoceratina sp.

Sheng Yin1, Rohan A Davis, Todd Shelper, Melissa L Sykes, Vicky M Avery, Mikael Elofsson, Charlotta Sundin, Ronald J Quinn.   

Abstract

Bioassay-guided fractionation of the CH(2)Cl(2)/MeOH extract of the Australian marine sponge Pseudoceratina sp. resulted in the purification of four new bromotyrosine alkaloids, pseudoceramines A-D (1-4), along with a known natural product, spermatinamine (5). The structures of 1-5 were determined by spectroscopic methods. Pseudoceramines A (1) and B (2) feature a rare bromotyrosyl-spermine-bromotyrosyl sequence, and pseudoceramine C (3) is the first example of bromotyrosine coupled with an N-methyl derivative of spermidine. Compounds 1-5 were screened for inhibition of toxin secretion by the type III secretion (T3S) pathway in Yersinia pseudotuberculosis. Compounds 2 and 5 inhibited secretion of the Yersinia outer protein YopE (IC(50) = 19 and 6 μM, respectively) and the enzyme activity of YopH (IC(50) = 33 and 6 μM, respectively).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850326     DOI: 10.1039/c1ob05581j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  14 in total

Review 1.  On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

Authors:  Bronwyn J E Lyons; Natalie C J Strynadka
Journal:  Medchemcomm       Date:  2019-06-20       Impact factor: 3.597

2.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

3.  Bioactive secondary metabolites from the Red Sea marine Verongid sponge Suberea species.

Authors:  Lamiaa A Shaala; Diaa T A Youssef; Jihan M Badr; Mansour Sulaiman; Alaa Khedr
Journal:  Mar Drugs       Date:  2015-03-24       Impact factor: 5.118

Review 4.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

5.  Design and characterization of a polyamine derivative inhibiting the expression of type III secretion system in Pseudomonas aeruginosa.

Authors:  Chao Wang; Xiaoling Liu; Jing Wang; Jianuan Zhou; Zining Cui; Lian-Hui Zhang
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

6.  Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis.

Authors:  Alicja Kuban-Jankowska; Kamlesh K Sahu; Pawel Niedzialkowski; Magdalena Gorska; Jack A Tuszynski; Tadeusz Ossowski; Michal Wozniak
Journal:  Oncotarget       Date:  2015-07-30

7.  The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.

Authors:  Caroline E Zetterström; Jenny Hasselgren; Olli Salin; Rohan A Davis; Ronald J Quinn; Charlotta Sundin; Mikael Elofsson
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

8.  Natural product polyamines that inhibit human carbonic anhydrases.

Authors:  Rohan A Davis; Daniela Vullo; Claudiu T Supuran; Sally-Ann Poulsen
Journal:  Biomed Res Int       Date:  2014-08-05       Impact factor: 3.411

9.  Aurintricarboxylic acid structure modifications lead to reduction of inhibitory properties against virulence factor YopH and higher cytotoxicity.

Authors:  Alicja Kuban-Jankowska; Kamlesh K Sahu; Magdalena Gorska; Pawel Niedzialkowski; Jack A Tuszynski; Tadeusz Ossowski; Michal Wozniak
Journal:  World J Microbiol Biotechnol       Date:  2016-08-25       Impact factor: 3.312

10.  Screening a Natural Product-Based Library against Kinetoplastid Parasites.

Authors:  Bilal Zulfiqar; Amy J Jones; Melissa L Sykes; Todd B Shelper; Rohan A Davis; Vicky M Avery
Journal:  Molecules       Date:  2017-10-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.